Zoetis (ZTS)
(Real Time Quote from BATS)
$174.19 USD
-0.20 (-0.12%)
Updated May 21, 2024 10:40 AM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZTS 174.19 -0.20(-0.12%)
Will ZTS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZTS
Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Zoetis (ZTS) Q1 Earnings: A Look at Key Metrics
Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Other News for ZTS
Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference
Positive Long-Term Growth Forecast for Zoetis with Strong Product Adoption and Robust Franchise Performance
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference
Aristotle Capital Core Equity Q1 2024 Commentary
Paul Tudor Jones Adjusts Portfolio, Major Reduction in NVIDIA Amidst Strategic Shifts